Upregulation of miR-142-5p in atherosclerotic plaques and regulation of oxidized low-density lipoprotein-induced apoptosis in macrophages

Molecular Medicine Reports

Volumn 11, Issue 5, 2015, Pages 3229-3234

  Xu, Ruijin ^a   Bi, Chenglong ^a   Song, Jiantao ^a   Wang, Lin ^a   Ge, Cheng ^a   Liu, Xinxin ^a   Zhang, Mei ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Apoptosis; Atherosclerosis; Mir 142 5p; Transforming growth factor 2

Indexed keywords

APOLIPOPROTEIN E; MICRORNA; MICRORNA 142 5P; OXIDIZED LOW DENSITY LIPOPROTEIN; TRANSFORMING GROWTH FACTOR BETA2; UNCLASSIFIED DRUG; LOW DENSITY LIPOPROTEIN; MIRN142 MICRORNA, HUMAN; MIRN142 MICRORNA, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ATHEROSCLEROTIC PLAQUE; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE EXPRESSION; GENE TARGETING; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; LIPID DIET; MACROPHAGE; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; UPREGULATION; WESTERN BLOTTING; ANIMAL; ATHEROSCLEROSIS; CELL LINE; CLUSTER ANALYSIS; DEFICIENCY; DISEASE MODEL; DRUG EFFECTS; EPITHELIUM CELL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; KNOCKOUT MOUSE; METABOLISM; RNA INTERFERENCE;

MURINAE; MUS;

ANIMALS; APOLIPOPROTEINS E; APOPTOSIS; ATHEROSCLEROSIS; CELL LINE; CLUSTER ANALYSIS; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; LIPOPROTEINS, LDL; MACROPHAGES; MICE; MICE, KNOCKOUT; MICRORNAS; PLAQUE, ATHEROSCLEROTIC; RNA INTERFERENCE; TRANSFORMING GROWTH FACTOR BETA2;

EID: 84922324424     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2015.3191     Document Type: Article

References (48)

1. Rodrigues AN, Abreu GR, Resende RS, Goncalves WL and Gouvea SA: Cardiovascular risk factor investigation: a pediatric issue. Int J Gen Med 6: 57-66, 2013.
2. Cesarino EJ, Vituzzo AL, Sampaio JM, Ferreira DA, Pires HA and de Souza L: Assessment of cardiovascular risk of patients with arterial hypertension of a public health unit. Einstein (Sao Paulo) 10: 33-38, 2012.
3. Pollex RL, Spence JD, House AA, et al: A comparison of ultrasound measurements to assess carotid atherosclerosis development in subjects with and without type 2 diabetes. Cardiovasc Ultrasound 3: 15, 2005.
4. Small EM and Olson EN: Pervasive roles of microRNAs in cardiovascular biology. Nature 469: 336-342, 2011.
5. Chang TC and Mendell JT: microRNAs in vertebrate physiology and human disease. Annu Rev Genomics Hum Genet 8: 215-239, 2007.
6. Mendell JT and Olson EN: MicroRNAs in stress signaling and human disease. Cell 148: 1172-1187, 2012.
7. He L and Hannon GJ: MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 5: 522-531, 2004.
8. Amelio I, Lena AM, Viticchie G, et al: miR-24 triggers epidermal differentiation by controlling actin adhesion and cell migration. J Cell Biol 199: 347-363, 2012.
9. Donners MM, Wolfs IM, Stöger LJ, et al: Hematopoietic miR155 deficiency enhances atherosclerosis and decreases plaque stability in hyperlipidemic mice. PLoS One 7: e35877, 2012.
10. Nossent AY, Hansen JL, Doggen C, Quax PH, Sheikh SP and Rosendaal FR: SNPs in microRNA binding sites in 3'-UTRs of RAAS genes influence arterial blood pressure and risk of myocardial infarction. Am J Hypertens 24: 999-1006, 2011.
11. Hergenreider E, Heydt S, Tréguer K, et al: Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nat Cell Biol 14: 249-256, 2012.
12. Kwanhian W, Lenze D, Alles J, et al: MicroRNA-142 is mutated in about 20% of diffuse large B-cell lymphoma. Cancer Med 1: 141-155, 2012.
13. Saito Y, Suzuki H, Tsugawa H, Imaeda H, Matsuzaki J, Hirata K, et al: Overexpression of miR-142-5p and miR-155 in gastric mucosa-associated lymphoid tissue (MALT) lymphoma resistant to Helicobacter pylori eradication. PLoS One 7: e47396, 2012.
14. von der Thüsen JH, van Berkel TJ and Biessen EA: Induction of rapid atherogenesis by perivascular carotid collar placement in apolipoprotein E-deficient and low-density lipoprotein receptor-deficient mice. Circulation 103: 1164-1170, 2001.
15. Wang XL, Zhang L, Youker K, et al: Free fatty acids inhibit insulin signaling-stimulated endothelial nitric oxide synthase activation through upregulating PTEN or inhibiting Akt kinase. Diabetes 55: 2301-2310, 2006.
16. Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W and Tuschl T: Identification of tissue-specific microRNAs from mouse. Curr Biol 12: 735-739, 2002.
17. Guo H, Ingolia NT, Weissman JS and Bartel DP: Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466: 835-840, 2010.
18. Baek D, Villén J, Shin C, Camargo FD, Gygi SP and Bartel DP: The impact of microRNAs on protein output. Nature 455: 64-71, 2008.
19. Pasquinelli AE, Hunter S and Bracht J: MicroRNAs: a developing story. Curr Opin Genet Dev 15: 200-205, 2005.
20. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
21. Farh KK, Grimson A, Jan C, et al: The widespread impact of mammalian MicroRNAs on mRNA repression and evolution. Science 310: 1817-1821, 2005.
22. Nazari-Jahantigh M, Wei Y, Noels H, et al: MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages. J Clin Invest 122: 4190-4202, 2012.
23. Sun X, Zhang M, Sanagawa A, et al: Circulating microRNA-126 in patients with coronary artery disease: correlation with LDL cholesterol. Thromb J 10: 16, 2012.
24. Zhang E and Wu Y: MicroRNAs: important modulators of oxLDL-mediated signaling in atherosclerosis. J Atheroscler Thromb 20: 215-227, 2013.
25. Xie C, Huang H, Sun X, et al: MicroRNA-1 regulates smooth muscle cell differentiation by repressing Kruppel-like factor4. Stem Cells Dev 20: 205-210, 2011.
26. Tréguer K, Heinrich EM, Ohtani K, Bonauer A and Dimmeler S: Role of the microRNA-17-92 cluster in the endothelial differentiation of stem cells. J Vasc Res 49: 447-460, 2012.
27. Chan YC, Roy S, Khanna S and Sen CK: Downregulation of endothelial microRNA-200b supports cutaneous wound angiogenesis by desilencing GATA binding protein 2 and vascular endothelial growth factor receptor2. Arterioscler Thromb Vasc Biol 32: 1372-1382, 2012.
28. Tserel L, Runnel T, Kisand K, et al: MicroRNA expression profiles of human blood monocyte-derived dendritic cells and macrophages reveal miR-511 as putative positive regulator of Toll-like receptor4. J Biol Chem 286: 26487-26495, 2011.
29. Urbich C, Kuehbacher A and Dimmeler S: Role of microRNAs in vascular diseases, inflammation, and angiogenesis. Cardiovasc Res 79: 581-588, 2008.
30. Virtue A, Mai J, Yin Y, et al: Structural evidence of anti-atherogenic microRNAs. Front Biosci (Landmark Ed) 16: 3133-3145, 2011.
31. Shan Z, Yao C, Li ZL, et al: Differentially expressed microRNAs at different stages of atherosclerosis in ApoE-deficient mice. Chin Med J (Engl) 126: 515-520, 2013.
32. Ding S, Liang Y, Zhao M, et al: Decreased microRNA-142-3p/5p expression causes CD4+ T cell activation and B cell hyperstimulation in systemic lupus erythematosus. Arthritis Rheum 64: 2953-2963, 2012.
33. Park S, Kang S, Min KH, et a: Age-associated changes in microRNA expression in bone marrow derived dendritic cells. Immunol Invest 42:179-190, 2013.
34. Gray EE and Cyster JG: Lymph node macrophages. J Innate Immun 4: 424-436, 2012.
35. Hutchinson JA, Riquelme P, Geissler EK and Fändrich F: Isolation of murine macrophages. Methods Mol Biol 6: 181-192, 2011.
36. Chadban SJ, Wu H and Hughes J: Macrophages and kidney transplantation. Semin Nephrol 30: 278-289, 2010.
37. Seimon TA, Nadolski MJ, Liao X, et al: Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress. Cell Metab 12: 467-482, 2010.
38. Liao X, Sluimer JC, Wang Y, et al: Macrophage autophagy plays a protective role in advanced atherosclerosis. Cell Metab 15: 545-553, 2012.
39. Tsukano H, Gotoh T, Endo M, et al: The endoplasmic reticulum stress-C/EBP homologous protein pathway-mediated apoptosis in macrophages contributes to the instability of atherosclerotic plaques. Arterioscler Thromb Vasc Biol 30: 1925-1932, 2010.
40. Inagaki Y, Yamagishi S, Amano S, et al: Interferon-gamma-induced apoptosis and activation of THP-1 macrophages. Life Sci 71: 2499-2508, 2002.
41. Jin ZG, Lungu AO, Xie L, Wang M, Wong C and Berk BC: Cyclophilin A is a proinflammatory cytokine that activates endothelial cells. Arterioscler Thromb Vasc Biol 24: 1186-1191, 2004.
42. de Winther MP, Kanters E, Kraal G and Hofker MH: Nuclear factor kappaB signaling in atherogenesis. Arterioscler Thromb Vasc Biol 25: 904-914, 2005.
43. Beswick EJ, Pinchuk IV, Earley RB, Schmitt DA and Reyes VE: Role of gastric epithelial cell-derived transforming growth factor beta in reduced CD4+ T cell proliferation and development of regulatory T cells during Helicobacter pylori infection. Infect Immun 79: 2737-2745, 2011.
44. Bartram U, Molin DG, Wisse LJ, Mohamad A, Sanford LP, Doetschman T, et al: Double-outlet right ventricle and overriding tricuspid valve reflect disturbances of looping, myocardialization, endocardial cushion differentiation, and apoptosis in TGF-beta(2)-knockout mice. Circulation 103: 2745-2752, 2001.
45. Singla DK, Singla RD, Lamm S and Glass C: TGF-β2 treatment enhances cytoprotective factors released from embryonic stem cells and inhibits apoptosis in infarcted myocardium. Am J Physiol Heart Circ Physiol 300: H1442-H1450, 2011.
46. Mallat Z, Gojova A, Marchiol-Fournigault C, et al: Inhibition of transforming growth factor-beta signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice. Circ Res 89: 930-934, 2001.
47. Lyons RE, Anthony JP, Ferguson DJ, et al: Immunological studies of chronic ocular toxoplasmosis: up-regulation of major histocompatibility complex class I and transforming growth factor beta and a protective role for interleukin-6. Infect Immun 69: 2589-2595, 2001.
48. Sun CK, Chua MS, He J and So SK: Suppression of glypican 3 inhibits growth of hepatocellular carcinoma cells through up-regulation of TGF-beta2. Neoplasia 13: 735-747, 2011.